Marketing Authorisation (MA) & Batch Release

Navigating the complex landscape of pharmaceutical regulations is critical for bringing safe and effective medicines to market. Silicon Pharma, as an MHRA-authorised Marketing Authorisation Holder (MAH), possesses in-house comprehensive expertise in regulatory compliance. We support our brands in effectively introducing and sustaining their presence across the UK, EU, and various global markets.

Marketing Authorisation (MA) & Batch Release

What We Offer - Key Feature

MA Holding

As the Marketing Authorisation Holder, we take full regulatory responsibility for our products, ensuring compliance with all necessary requirements.

Product Launch

Comprehensive support for navigating regulatory pathways, preparing dossiers, and meeting submission requirements across diverse markets, including the UK and Europe.

Distribution

Seamless distribution to hospitals across the UK with options for same-day and next-day delivery, ensuring critical products reach their destinations promptly.

Life Cycle Management

Handling variations, renewals, transfers, and withdrawals of MAs.

Batch Release & Testing

Facilitating the release of medicinal products to the market, including coordination with certified testing laboratories.

Quality Assurance & Compliance Audits

Ensuring adherence to Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) standards.

Pharmacovigilance Support

Assistance with post-market safety surveillance and reporting requirements.

Regulatory Liaising

Acting as your direct liaison with regulatory authorities like the MHRA.

Our core strengths

Why Choose Silicon Pharma for Regulatory Compliance?

Proven expertise

Over 15 years of experience in UK and international pharmaceutical regulations.

MHRA & ISO accredited

Demonstrating the highest standards of quality and compliance.

Dedicated regulatory team

Our in-house specialists stay abreast of evolving regulatory landscapes.

Streamlined market access

We simplify complex processes, enabling faster product launches.

Our Process

From initial consultation and strategic planning to dossier submission and post-market vigilance, we partner with you at every stage to ensure regulatory success.

Who Benefits

Pharmaceutical manufacturers, biotech companies, parallel importers, and distributors seeking to market products in the UK/EU.